Stem cell guidelines open door to more permissive research on human embryos
By Kelly Servick,
Science
| 05. 26. 2021
The world’s largest stem cell society this week signaled a willingness to reconsider a long-standing restriction on laboratory efforts to grow and study human embryos. In new guidelines, the International Society for Stem Cell Research (ISSCR) also spotlights a possible alternative to using embryos that might be less ethically fraught: emerging methods to model stages of human development with stem cells. ISSCR’s influential guidelines previously put the culture of human embryos beyond 14 days postfertilization in its most restrictive category three: “prohibited research activities.” The new guidelines, drafted by a task force of scientists and ethicists, omit longer embryo culture from this category and encourage a public discussion about allowing it.
The guidelines aren’t legally enforceable. Laws limiting embryo research to either 14 days or formation of a structure called the primitive streak exist in several countries, including the United Kingdom, Sweden, and South Korea. But ISSCR “has an important soft power,” says Annelien Bredenoord, a bioethicist at the University Medical Center Utrecht who is a member of ISSCR’s ethics committee but not part of the guideline task force...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...